Pharmanutra Logo

Pharmanutra

Researches and markets nutritional supplements & medical devices for all ages.

PHN | XMIL

Overview

Corporate Details

ISIN(s):
IT0005274094
LEI:
815600F8217BC7733697
Country:
Italy
Address:
VIA CAMPODAVELA, 1, 56122 PISA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 2003, PharmaNutra is a company specializing in the research, development, and marketing of nutritional supplements and medical devices. The firm emphasizes scientific innovation and manages the entire production process, from proprietary raw materials to finished goods. Through its in-house research centers and labs, it pioneers studies to create unique and effective products. The portfolio focuses on addressing nutritional deficiencies, such as minerals and vitamins, and supporting musculoskeletal and joint health for consumers of all ages.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-03 13:13
Transaction in Own Shares
Initiation of share buy-back program
English 243.9 KB
2025-10-03 13:12
Transaction in Own Shares
Avvio del programma di acquisti di azioni proprie
Italian 232.8 KB
2025-10-01 09:00
Investor Presentation
Eccellenze del Made in Italy | Presentazione
English 5.0 MB
2025-09-12 10:35
Interim Report
Half Year Financial Report 2025
English 3.3 MB
2025-09-12 10:34
Interim Report
Relazione finanziaria semestrale 2025
Italian 3.4 MB
2025-09-12 10:33
Report Publication Announcement
CS_Disponibilità Relazione Semestrale 2025 || Availability Half Year financial …
Italian 269.4 KB
2025-09-08 17:55
Earnings Release
PHN: The Board of Directors approved the results as of 30 June 2025
English 443.8 KB
2025-09-08 17:55
Earnings Release
PHN: il Consiglio di Amministrazione ha approvato i risultati al 30 giugno 2025
Italian 370.0 KB
2025-08-04 18:05
Regulatory News Service
PR PHARMANUTRA SPA - Sidevit B12 sales
English 465.8 KB
2025-08-04 18:04
Earnings Release
CS PHARMANUTRA SPA - Vendite Sidevit B12
Italian 259.1 KB
2025-06-03 08:00
Regulatory News Service
Pharmanutra: Lancio ApportAL Boost
Italian 189.4 KB
2025-06-03 08:00
Regulatory News Service
Pharmanutra: Launch of ApportAL Boost
English 241.0 KB
2025-05-27 10:47
Investor Presentation
MIDCAP Road Show - Paris
English 3.4 MB
2025-05-15 15:26
Registration Form
Statuto sociale aggiornato
Italian 295.1 KB
2025-05-15 15:25
Pre-Annual General Meeting Information
Verbale Assemblea ordinaria e straordinaria degli Azionisti del 26 aprile 2025
Italian 9.4 MB

Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharmanutra via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.